Synergistic suppression of the hyperacute form of experimental allergic encephalomyelitis by tilorone and cycloleucine.
D000596:Amino Acids / Q000627:therapeutic use*; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003515:Cycloleucine / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004357:Drug Synergism; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000628:therapy*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D007165:Immunosuppression Therapy; D051381:Rats; D013994:Tilorone / Q000627:therapeutic use*
D000596:Amino Acids; D000961:Antilymphocyte Serum; D005449:Fluorenes; D003515:Cycloleucine; D003520:Cyclophosphamide; D013994:Tilorone